myAllergyPal® is a medical tracking app for United Allergy Services patients, providing immunotherapy dosage logs and pollen forecasts on iOS and Android.
Product velocity
Dormant
Daily rank 🇺🇸
—
Medical
Sentiment
2.7
158 reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Patients hire the app to manage complex immunotherapy schedules, but the current technical failures force them to revert to manual logs, breaking the adherence loop.
For Patients currently enrolled in the United Allergy Services immunotherapy protocol and individuals seeking information on allergy testing.
What does it look like?
Key features
Digital tracking of immunotherapy treatment progress and injection history
Four-day localized pollen level and forecast data
Push notifications for scheduled immunotherapy doses and clinic appointments
How much does it cost?
The app operates as a free utility to support the primary business of in-office allergy testing and immunotherapy treatment.
Velocity
Dormant developmentopaqueShow more...
The app has been inactive for exactly one year, with no updates recorded since May 2025. The last known activity consisted of minor bug fixes for dose reminders on both iOS and Android platforms. Given the lack of any development activity over the past 12 months, the app is classified as a zombie project.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews frustrated. Users appreciate allergy tracking features provide helpful reminders for medication schedules when the application functions correctly, but report persistent server connectivity errors prevent users from logging injections or accessing their medical data.
How are ratings & reviews evolving?
What users say, by theme
- Allergy tracking features provide helpful reminders for medication schedules when the application functions correctly
- Persistent server connectivity errors prevent users from logging injections or accessing their medical data
66 of 99 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for myAllergyPal®
How's the Medical market?
The app holds a #183 position in the Canadian Medical category, reflecting its niche role as a clinical adherence tool rather than a mass-market health app.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for myAllergyPal®
Where is it heading?
The medical tracking category is shifting toward offline-first reliability, leaving myAllergyPal® exposed due to its dependency on constant server connectivity. Continued failure to stabilize the login process will accelerate patient churn back to manual documentation, effectively nullifying the app's value as a clinical adherence tool.
- Persistent server connectivity failures post-update erode user trust, forcing patients to revert to manual paper logs for their immunotherapy tracking.
- Launch crashes following the latest release prevent access to the dosage log, which compounds the existing rating drag on Android.
The SWOT
- Proprietary integration with clinical immunotherapy protocols
- Direct B2B distribution channel to existing patients
- Implement local data storage for tracking continuity
- Add PDF export for clinical progress sharing
Next best moves
Rebuild server authentication handshake because login failures are the top complaint → restore basic utility
+ 1 more prioritized moveThe counter-intuitive read
The app's low rating is actually a signal of high user intent…
Read the full takeFeature gaps
PDF clinical report export (available in CBT Thought Diary App but absent here) +1
Since the last report: The app's competitive position has declined due to critical technical instability, forcing a shift in roadmap priorities toward server authentication and offline data access.
Bottom line
The app fails its primary job of clinical adherence due to persistent server instability, so the PM must prioritize local data caching to ensure patients can log doses regardless of connectivity.
Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated